Goserelin and locally advanced prostate cancer: new indication. Pros and cons.  [electronic resource] 

 -  Prescrire international  Jun 2000 
 - 75-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1167-7422 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Clinical Trials as Topic<br/>Endocrine System Diseases--chemically induced<br/>Erectile Dysfunction--chemically induced<br/>France<br/>Gonadotropin-Releasing Hormone--agonists<br/>Goserelin--administration & dosage<br/>Humans<br/>Libido--drug effects<br/>Male<br/>Prostatic Neoplasms--drug therapy<br/>Treatment Outcome<br/>Urinary Incontinence--chemically induced